Effects of Sourdough Fermentation Duration and Acid Development on Postprandial Blood Glucose in Prediabetic Adults
NCT ID: NCT06925451
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
15 participants
INTERVENTIONAL
2025-04-04
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Breads Made With Triticum Heritage Varieties: Effect on Post-prandial Glycemia and Insulinemia
NCT03710200
Glycemic and Insulinemic Response of Durum Wheat Bread
NCT06152874
Effect of Pea Flour in Bread on Blood Glucose
NCT03506932
Testing the Effect of Whole-wheat Sourdough Bread Compared to White Bread on Healthy Individuals
NCT02936362
Bread Structure and Postprandial Metabolic Responses
NCT05691686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study examined the acute effect of varying lengths of sourdough fermentation times on postprandial blood glucose levels over a 4-week period in adults with prediabetes (as evidenced by fasting glucose ≥100 or diagnosis by physician), but not taking diabetic medications. For each trial, the sourdough bread was ingested after an overnight fasting period in order to evaluate the effects of the bread when incorporated into the diet in place of breads made with baker's yeast. The goal of this crossover randomized trial was to assess the relationship between lengthened fermentation time, meaning an increased amount of lactic acid and acetic acid in the bread product, and glycemic and insulinemic response.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sourdough bread 24
24 hours fermentation
sourdough bread 24
fermentation time=24 hours
Control bread
12 hours fermentation
yeast bread
no fermentation
sourdough bread 48
48 hours fermentation
sourdough bread 48
fermentation time=48 hours
sourdough bread 72
72 hours fermentation
sourdough bread 72
fermentation time=72 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sourdough bread 24
fermentation time=24 hours
sourdough bread 48
fermentation time=48 hours
sourdough bread 72
fermentation time=72 hours
yeast bread
no fermentation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carol Johnston
Professor and Senior Associate Dean
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
850 PBC
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00021470
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.